3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
19
Glioma
12
Brain Neoplasms
8
Astrocytoma
7
Neoplasms
6
Neuroblastoma
5
Gliosarcoma
3
Diffuse Intrinsic Pontine Glioma
3
Spinal Cord Neoplasms
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Recurrence
2
Pancreatic Neoplasms
2
Oligodendroglioma
2
Melanoma
2
Medulloblastoma
2
Wilms Tumor
1
Rhabdoid Tumor
1
Refractory Solid Tumors
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasm Metastasis
1
Melanoma, Cutaneous Malignant
1
Lymphoma, Follicular
1
Hepatoblastoma
1
Ganglioneuroblastoma
1
Interventions
fludarabine
11
Cyclophosphamide
10
fludarabine phosphate
8
Whole-Body Irradiation
7
Specimen Handling
7
Cytarabine
7
Biopsy
7
venetoclax
6
Busulfan
6
Azacitidine
6
Mycophenolic Acid
5
Melphalan
5
Injections
5
CPX-351
5
decitabine and cedazuridine drug combination
4
Tacrolimus
4
Peripheral Blood Stem Cell Transplantation
4
Granulocyte Colony-Stimulating Factor
4
Filgrastim
4
Cyclosporine
4
ivosidenib
3
X-Rays
3
Stem Cell Transplantation
3
Magnetic Resonance Spectroscopy
3
treosulfan
2
ruxolitinib
2
luspatercept
2
gilteritinib
2
Sirolimus
2
Photons
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
Temozolomide
×
30 days
×
Clear all
No trials found.